INSM12 (formerly IA-1) is a zinc finger transcription factor originally isolated from a human insulinoma subtraction library (1). Functional analysis of INSM1 revealed that multiple downstream target genes and upstream regulatory proteins of the INSM1 gene are closely associated with pancreatic endocrine cell differentiation (2-4). Global deletion of the INSM1 gene was embryonic lethal and resulted in abnormal -cell development (5) as well as impaired sympatho-adrenal lineage development (6). The expression patterns of INSM1 in both humans and rodents are restricted to the fetal neuroendocrine system and silenced in adult tissues (1, 7-9). However, the INSM1 gene is reactivated in tumors of neuroendocrine origin, suggesting that de-differentiation events occur in neuroendocrine tumors that mimic normal embryonic development. Embryonic development requires the generation of cells in appropriate numbers and the timely acquisition of specialized cell functions (10). Specialization occurs gradually over multiple rounds of cell division, with the end point being a nondividing terminally differentiated cell. Usually, cell fate determination is controlled in part by external signals and/or differentiation factors that govern cells to either enter or exit the cell cycle. Our previous study revealed a direct interaction between INSM1 and cyclin D1 (11). Therefore, we hypothesize that INSM1 could not only function as a transcription factor in regulating its downstream target genes but also plays an important role in switching between cellular proliferation and differentiation pathways.In the present study, the cyclin box of cyclin D1 was identified to be essential for INSM1 binding. Conversely, a proline-rich N-terminal region (amino acids 43-58) in INSM1 facilitates binding to cyclin D1. The cyclin box is known to be the main binding site for cyclin-dependent kinase 4 (CDK4) (12). Competitive immunoprecipitation of cyclin D1 with INSM1 or CDK4 demonstrated that INSM1 could interrupt CDK4 binding, subsequently induced Rb protein hypophosphorylation, and cell cycle arrest. We employed an INSM1 Tet-on system in Cos-7 and Panc-1 cells. Induction of INSM1 in these cells results in cell cycle arrest and inhibition of cellular proliferation.
EXPERIMENTAL PROCEDURESCell Lines and Chemicals-An African green monkey kidney cell line (Cos-7) and a human pancreatic carcinoma cell line (Panc-1) were obtained from ATCC and maintained according to the ATCC recommendation. TC-1 cells were kindly provided by Dr. E. H. Leiter (Jackson Laboratory, Bar Harbor, ME). Antibodies to CDK4 (C-22), cyclin D1, phospho-Rb 780 , and Rb were purchased from BD Biosciences (Palo Alto, CA). Anti-GFP was purchased from Clontech (Palo Alto, CA). A mouse anti-INSM1 monoclonal antibody (6-1-1) was generated against the C-terminal peptide of the INSM1 protein. Anti-FLAG and anti-actin antibodies were purchased from Sigma. Anti-hemagglutinin antibody was obtained from BIOSOURCE (Camarillo, CA). * This work was supported, in whole or in part, by National Insti...